{"id":"W2508843946","doi":"10.1016/j.thromres.2016.08.013","title":"Ciraparantag for enoxaparin reversal: Adding to the evidence","year":2016,"lang":"en","type":"editorial","venue":"Thrombosis Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Population Health Research Institute; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Edoxaban; Heparin; Low molecular weight heparin; Pharmacology; Chemistry; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01578424,0.003558076,0.008671095,0.004735902,0.002617692,0.01173367,0.004960178,0.02584425,0.007040422],"category_scores_gemma":[0.0539304,0.001605976,0.004535092,0.002524663,0.003006139,0.007670076,0.002214461,0.03358372,0.005158108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003433354,"about_ca_system_score_gemma":0.005818346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001349111,"about_ca_topic_score_gemma":0.003999055,"domain_scores_codex":[0.9870738,0.00269863,0.003094036,0.001108105,0.005421432,0.0006039044],"domain_scores_gemma":[0.9392029,0.0359618,0.004204785,0.001035341,0.01461755,0.004977607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002415376,0.00004683558,0.00008441322,0.001989769,0.0002547491,0.0002467063,0.00003846657,0.00004600159,0.0001013495,0.0004756817,0.9759681,0.02050623],"study_design_scores_gemma":[0.001109818,0.0001971738,0.0006483471,0.00651976,0.001278967,0.0008918425,0.0001521087,0.0004776599,0.0003053757,0.002978275,0.9853453,0.00009542953],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00006542224,0.03008797,0.0001647648,0.05836887,0.910428,0.00003203983,0.00005825682,0.00004748566,0.0007471829],"genre_scores_gemma":[0.0003502446,0.01342019,0.0001461589,0.03034964,0.9543177,0.00001893991,0.00002043059,0.00001869767,0.001358014],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.02584425,"threshold_uncertainty_score":0.08347601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4059603917357699,"score_gpt":0.552289230322627,"score_spread":0.1463288385868571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}